Skip to main content
. 2017 Apr 8;8(24):38668–38681. doi: 10.18632/oncotarget.16961

Figure 5.

Figure 5

(A) Tumor proliferative index is correlated with TCGA breast cancer somatic mutation burden. (B) Q-Q plot of p-values derived from gene mutation burden-proliferative index associations. (C) TCGA breast tumors containing non-synonymous mutations in RELN have higher proliferative index compared to wild-type. (D) Kaplan-Meier survival plot shows reduced expression or protein-altering mutations in RELN are markers of poor prognosis in patients with basal breast cancer.